BOSTON, Sept. 15 – “We’ve got a large tasks ahead of us” explaining the role of pharmacogenomics in medical and healthcare practice, said Wayne Rosenkrans, director of Business Strategy, External Scientific Affairs at AstraZeneca Pharmaceuticals, during a panel discussion today at the IBC Molecular Diagnostics and Personalized Medicine conference.